Shandong Rongyuan

Shandong Rongyuan Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. Based in Weifang, Shandong Province, the company operates GMP-compliant manufacturing facilities and supplies products to both domestic and international markets. Their portfolio primarily focuses on metabolic diseases, particularly anti-diabetic medications such as metformin hydrochloride and gliclazide. The company provides contract manufacturing services and is recognized for its high-capacity production of essential chemical raw materials for the healthcare industry. Shandong Rongyuan holds several international quality certifications, including the European CEP, facilitating its role as a key supplier in the global generic drug supply chain.